KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Inventory (2020 - 2023)

Ginkgo Bioworks Holdings (DNA) has disclosed Inventory for 4 consecutive years, with $70000.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Inventory fell 98.81% year-over-year to $70000.0, compared with a TTM value of $70000.0 through Sep 2023, down 98.81%, and an annual FY2022 reading of $4.4 million, up 29.8% over the prior year.
  • Inventory was $70000.0 for Q3 2023 at Ginkgo Bioworks Holdings, down from $391000.0 in the prior quarter.
  • Across five years, Inventory topped out at $8.7 million in Q1 2022 and bottomed at $70000.0 in Q3 2023.
  • Average Inventory over 4 years is $4.0 million, with a median of $3.4 million recorded in 2021.
  • The sharpest move saw Inventory surged 68.68% in 2022, then crashed 98.81% in 2023.
  • Year by year, Inventory stood at $2.7 million in 2020, then increased by 22.88% to $3.4 million in 2021, then grew by 29.8% to $4.4 million in 2022, then crashed by 98.4% to $70000.0 in 2023.
  • Business Quant data shows Inventory for DNA at $70000.0 in Q3 2023, $391000.0 in Q2 2023, and $2.5 million in Q1 2023.